$0.81
+0.13
(+19.14%)▲
Insights on Neptune Wellness Solutions Inc.
Revenue is down for the last 2 quarters, 16.41M → 8.73M (in $), with an average decrease of 46.8% per quarter
Netprofit is up for the last 2 quarters, -35.90M → -890.19K (in $), with an average increase of 3933.4% per quarter
In the last 1 year, Haleon Plc Spon Ads has given 24.4% return, outperforming this stock by 122.1%
14.81%
Downside
Day's Volatility :16.81%
Upside
2.34%
23.36%
Downside
52 Weeks Volatility :98.51%
Upside
98.05%
Period | Neptune Wellness Solutions Inc. | Russel 2000 | Index (Russel 2000) |
---|---|---|---|
3 Months | -86.82% | 0.0% | 0.0% |
6 Months | -91.01% | 0.0% | 0.0% |
1 Year | -97.67% | -6.2% | -6.2% |
3 Years | -99.97% | -2.8% | -2.8% |
Market Capitalization | 1.4M |
Book Value | - $8.31 |
Dividend Share | 0.0 |
Dividend Yield | 5.15% |
Earnings Per Share (EPS) | -44.13 |
PEG Ratio | 0.0 |
Wall Street Target Price | 26.25 |
Profit Margin | -78.86% |
Operating Margin TTM | -50.67% |
Return On Assets TTM | -47.04% |
Return On Equity TTM | -818.48% |
Revenue TTM | 43.7M |
Revenue Per Share TTM | 95.08 |
Quarterly Revenue Growth YOY | -27.1% |
Gross Profit TTM | -8.5M |
EBITDA | -34.0M |
Diluted Eps TTM | -44.13 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.16 |
EPS Estimate Next Year | -0.83 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 3140.74%
Sell
Neutral
Buy
Neptune Wellness Solutions Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Neptune Wellness Solutions Inc. | -10.42% | -91.01% | -97.67% | -99.97% | -99.98% |
![]() Neurocrine Biosciences Inc. | 5.98% | 26.0% | -10.64% | 19.59% | 28.63% |
![]() Haleon Plc Spon Ads | 6.86% | 6.2% | 24.38% | 15.65% | 15.65% |
![]() Zoetis Inc. | 11.97% | 9.23% | 14.05% | 9.61% | 87.27% |
![]() Viatris Inc. | 3.28% | -0.54% | -17.23% | -45.72% | -44.12% |
![]() Catalent, Inc. | -0.88% | 8.65% | -21.07% | -58.84% | -0.2% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Neptune Wellness Solutions Inc. | NA | NA | 0.0 | -4.16 | -8.18 | -0.47 | 0.05 | -8.31 |
![]() Neurocrine Biosciences Inc. | 59.48 | 59.48 | 1.87 | 2.29 | 0.11 | 0.09 | 0.01 | 20.39 |
![]() Haleon Plc Spon Ads | 25.21 | 25.21 | NA | 0.41 | 0.06 | 0.04 | 0.01 | 1.78 |
![]() Zoetis Inc. | 36.78 | 36.78 | 3.53 | 5.42 | 0.47 | 0.14 | 0.01 | 11.05 |
![]() Viatris Inc. | 6.19 | 6.19 | NA | 2.95 | 0.09 | 0.03 | 0.05 | 17.39 |
![]() Catalent, Inc. | 211.02 | NA | 1.18 | 1.01 | -0.22 | 0.0 | 0.0 | 21.58 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Neptune Wellness Solutions Inc. | Sell | $1.4M | -99.98% | NA | -78.86% |
![]() Neurocrine Biosciences Inc. | Buy | $11.1B | 28.63% | 59.48 | 10.71% |
![]() Haleon Plc Spon Ads | Buy | $39.6B | 15.65% | 25.21 | 11.05% |
![]() Zoetis Inc. | Buy | $82.7B | 87.27% | 36.78 | 27.24% |
![]() Viatris Inc. | Hold | $11.2B | -44.12% | 6.19 | 11.84% |
![]() Catalent, Inc. | Hold | $7.2B | -0.2% | 211.02 | -22.36% |
Sabby Management LLC
Penserra Capital Management, LLC
UBS Group AG
JPMorgan Chase & Co
Citigroup Inc
The Toronto-Dominion Bank
Neptune Wellness Solutions Inc.’s price-to-earnings ratio stands at None
Read Morevision: provide great products and solutions that deliver optimal health and wellness. mission: leverage our scientific and innovative expertise to create and provide our customers globally with the best nutritional products and wellness solutions. neptune is active in five main areas: cannabis business: neptune is working to develop unique extracts and formulations in the legal cannabis wellness field. ingredients: leveraging our global network of suppliers, we source a variety of marine oils, seed oils and specialty ingredients. turnkey solutions: we develop product concepts in collaboration with our customers (branded marketers) as turnkey finished supplements that are ready for sale under their brand, primarily as softgels, capsules, liquids and powders. through our global network of suppliers, we source ingredients and formulate the ideal product. the ingredients are sent to third-party manufacturers, where the formula is developed in a liquid, powder or capsule form and then pack
Organization | Neptune Wellness Solutions Inc. |
Employees | 50 |
CEO | Mr. Michael Cammarata |
Industry | All Other Miscellaneous Chemical Product and Preparation Manufacturing |
Asymmetric Smart Alpha S&p 500 Etf
$0.81
+19.14%
Advisorshares Alpha Dna Equity Sentiment Etf
$0.81
+19.14%
Liberty Tripadvisor Hdg-b
$0.81
+19.14%
Tempo Automation Holdings Inc
$0.81
+19.14%
Falcon's Beyond Global Inc
$0.81
+19.14%
Jaguar Global Growth Corporation I
$0.81
+19.14%
Missfresh Ltd
$0.81
+19.14%
Shuaa Partners Acquisition Corp I
$0.81
+19.14%
Rose Hill Acquisition Corp
$0.81
+19.14%